Note: Ingredients listed on restricted chemical lists
EC/CAS
232-679-6/9005-25-8
Name of the chemical
Starch
Concentration
*
EC/CAS
232-680-1/9005-32-7
Name of the chemical
alginic acid
Concentration
*
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
*
General Information
Version
2.0
Revision date
2013-10-31
Product name
ALBON BOLUSES 5g, 15g
Product Synonyms
Sulfadimethoxine Boluses 5g, 15g
Chemical name
Mixture
1.2.1 Relevant identified uses
Veterinary product used as antibiotic agent
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Zoetis Inc
e-mail address of the competent person responsible for the Safety Data Sheet
VMIPSrecords@zoetis.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Appearance White to off-white oblong, biconvex bolus tablet . Classification of the Substance or Mixture GHS - Classification Skin Sensitization: Category 1 EU Classification EU Indication of danger Irritant EU Symbol Xi EU Risk Phrases R43 - May cause sensitization by skin contact.
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P272 - Contaminated work clothing should not be allowed out of the workplace P280 - Wear protective gloves/protective clothing/eye protection/face protection P302+ P352 - IF ON SKIN: Wash with plenty of soap and water P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P362 - Take off contaminated clothing and wash before reuse P501 - Dispose of contents/container in accordance with all local and national regulations
Other hazards
Short Term Contact with sulfonamides may cause dermatitis. Allergic skin reaction may occur based on effects of other sulfonamides. Dust may cause irritation . Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Known Clinical Effects As in all sulfonamide therapy, the following reactions may occur including nausea, vomiting, diarrhea, inflammation of the liver and pancreas, blood disorder, drug fever, skin rash, infection of the conjunctiva and sclera, blood in the urine and crystalluria. Australian Hazard Classification (NOHSC): Note
Hazardous Ingredients
Non-Dangerous Goods This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
Skin Sensitization: Category 1 EU Classification: EU Indication of danger: Irritant EU Symbol: Xi EU Risk Phrases: R43 - May cause sensitization by skin contact. Label Elements
